Although the regulation of HMGA2 by let-7 miRNAs is not unique to AT/RT and has been previously discussed in breast [157], lung [158], and ovarian [159] cancers, it provides a new therapeutic avenue in management of AT/RT tumours. Here, HMGA2 is linked to cancer.